Which is the best anticoagulant for whole blood aggregometry platelet function testing? Comparison of six anticoagulants and diverse storage conditions

References

• Paniccia R, Antonucci E, Maggini N, Miranda M, Gori AM, Marcucci R, Giusti B, Balzi D, Prisco D, Abbate R. Comparison of methods for monitoring residual platelet reactivity after clopidogrel by point-of-care tests on whole blood in high-risk patients. Thromb Haemost 2010; 104: 287–292
   PubMed Web of Science ®Google Scholar
• Sibbing D, Morath T, Braun S, Stegherr J, Mehilli J, Vogt W, Schömig A, Kastrati A, von Beckerath N. Clopidogrel response status assessed with Multiplate point-of-care analysis and the incidence and timing of stent thrombosis over six months following coronary stenting. Thromb Haemost 2010; 103: 151–159
   PubMed Web of Science ®Google Scholar
• Tóth O, Calatzis A, Penz S, Losonczy H, Siess W. Multiple electrode aggregometry: A new device to measure platelet aggregation in whole blood. Thromb Haemost 2006; 96: 781–788
   PubMed Web of Science ®Google Scholar
• Ivandic B, Schlick P, Staritz P, Kurz K, Katus H, Giannitsis E. Determination of clopidogrel resistance by whole blood platelet aggregometry and inhibitors of the P2Y12 receptor. Clin Chem 2006; 52: 383–388
   PubMed Web of Science ®Google Scholar
• Ivandic B, Giannitsis E, Schlick P, Staritz P, Katus H, Hohlfeld T. Determination of aspirin responsiveness by use of whole blood platelet aggregometry. Clin Chem 2007; 53: 614–619
   PubMed Web of Science ®Google Scholar
• Neubauer H, Kaiser A, Busse B, Mügge A. Identification, evaluation and treatment of prasugrel low-response after coronary stent implantation - a preliminary study. Thromb Res 2010; 126: e389–391
   Web of Science ®Google Scholar
• Neubauer H, Kaiser AF, Endres HG, Krüger JC, Engelhardt A, Lask S, Pepinghege F, Kusber A, Mügge A. Tailored antiplatelet therapy can overcome clopidogrel and aspirin resistance - The BOchum CLopidogrel and Aspirin Plan (BOCLA-Plan) to improve antiplatelet therapy. BMC Med 2011; 9: 3
   PubMed Web of Science ®Google Scholar
• Breddin H. Can platelet aggregometry be standardized?. Platelets 2005; 16(3–4)151–158
   PubMed Web of Science ®Google Scholar
• Breddin K, Ziemen M, Bauer O, Herrmann W, Schaudinn L, Schlosser U, Winterhagen A, Krzywanek H. Time and temperature dependent changes of ADP - and collagen-induced and “spontaneous” aggregation. Thromb Res 1980; 19(4–5)621–638
   PubMedGoogle Scholar
• Mani H, Hellis M, Lindhoff-Last E. Platelet function testing in hirudin and BAPA anticoagulated blood. Clin Chem Lab Med 2011; 49: 501–507
   PubMed Web of Science ®Google Scholar
• Truss N, Armstrong P, Liverani E, Vojnovic I, Warner T. Heparin but not citrate anticoagulation of blood preserves platelet function for prolonged periods. J Thromb Haemost 2009; 7: 1897–1905
   PubMed Web of Science ®Google Scholar
• Belcher P, Muriithi E, Day S, Wheatley D. Platelet aggregatory responses to low-dose collagen are maintained in hirudin-anticoagulated whole blood for 24 h when stored at room temperature. Platelets 2001; 12: 34–36
   PubMed Web of Science ®Google Scholar
• Haubelt H, Vogt A, Hellstern P. Preservation of platelet aggregation and dense granule secretion during extended storage of blood samples in the presence of a synthetic dual inhibitor of factor Xa and thrombin. Platelets 2008; 19: 496–501
   PubMed Web of Science ®Google Scholar
• Hellstern P, Stürzebecher U, Wuchold B, Haubelt H, Seyfert U, Bauer M, Vogt A, Stürzebecher J. Preservation of in vitro function of platelets stored in the presence of a synthetic dual inhibitor of factor Xa and thrombin. J Thromb Haemost 2007; 5: 2119–2126
   PubMed Web of Science ®Google Scholar
• Tauer JT, Lohse J, König S, Knöfler R. Investigations of platelet function in whole blood with BAPA as anticoagulant. Transfus Med Hemother 2010; 37: 284–288
   PubMedGoogle Scholar
• Kaiser AF, Endres HG, Mügge A, Neubauer H. BAPA, a synthetic dual inhibitor of Factor Xa and Thrombin, extends the storage-time to a maximum of 12 h in ADP- and 24 h in arachidonic acid-induced impedance aggregometry. Scand J Clin Lab Invest 2011; 71: 253–256
   PubMed Web of Science ®Google Scholar
• Kalb M, Potura L, Scharbert G, Kozek-Langenecker S. The effect of ex vivo anticoagulants on whole blood platelet aggregation. Platelets 2009; 20: 7–11
   PubMed Web of Science ®Google Scholar
• Johnson A, Dovlatova N, Heptinstall S. Multiple electrode aggregometry and P2Y(12) antagonists. Thromb Haemost 2008; 99: 1127–1129
   PubMed Web of Science ®Google Scholar
• Seyfert U, Haubelt H, Vogt A, Hellstern P. Variables influencing Multiplate(TM) whole blood impedance platelet aggregometry and turbidimetric platelet aggregation in healthy individuals. Platelets 2007; 18: 199–206
   PubMed Web of Science ®Google Scholar
• Ben-Dor I, Kleiman NS, Lev E. Assessment, mechanisms, and clinical implication of variability in platelet response to aspirin and clopidogrel therapy. Am J Cardiol 2009; 104: 227–233
   PubMed Web of Science ®Google Scholar
• Jin RC, Voetsch B, Loscalzo J. Endogenous mechanisms of inhibition of platelet function. Microcirculation 2005; 12: 247–258
   PubMed Web of Science ®Google Scholar
• Hawiger J. Platelet secretory pathways: An overview. Methods Enzymol 1989; 169: 191–195
   PubMedGoogle Scholar
• Golański J, Pietrucha T, Baj Z, Greger J, Watala C. Molecular insights into the anticoagulant-induced spontaneous activation of platelets in whole blood-various anticoagulants are not equal. Thromb Res 1996; 83: 199–216
   PubMed Web of Science ®Google Scholar
• Glusa E. Platelet aggregation in recombinant-hirudin-anticoagulated blood. Haemostasis 1991; 21(Suppl 1)116–120
   PubMedGoogle Scholar
• Cardinal D, Flower R. The electronic aggregometer: A novel device for assessing platelet behavior in blood. J Pharmacol Meth 1980; 3: 135–158
   PubMedGoogle Scholar
• McGlasson DL, Fritsma GA. Whole blood platelet aggregometry and platelet function testing. Semin Thromb Hemost 2009; 35: 168–180
   PubMed Web of Science ®Google Scholar
• Gorog DA, Sweeny JM, Fuster V. Antiplatelet drug ‘resistance’. Part 2: Laboratory resistance to antiplatelet drugs-fact or artifact?. Nat Rev Cardiol 2009; 6: 365–373
   PubMed Web of Science ®Google Scholar
• Wallén N, Ladjevardi M, Albert J, Bröijersén A. Influence of different anticoagulants on platelet aggregation in whole blood; a comparison between citrate, low molecular mass heparin and hirudin. Thromb Res 1997; 87: 151–157
   PubMed Web of Science ®Google Scholar
• Edwards A, Jakubowski JA, Rechner AR, Sugidachi A, Harrison P. Evaluation of the INNOVANCE PFA P2Y test cartridge: Sensitivity to P2Y(12) blockade and influence of anticoagulant. Platelets Aug 17, 2011, [Epub ahead of print], (DOI:10.3109/09537104.2011.601361)
   PubMedGoogle Scholar
• Izaguirre G, Swanson R, Raja SM, Rezaie AR, Olson ST. Mechanism by which exosites promote the inhibition of blood coagulation proteases by heparin-activated antithrombin. J Biol Chem 2007; 282: 33609–33622
   PubMedGoogle Scholar
• Lindhout T, Blezer R, Hemker H. The anticoagulant mechanism of action of recombinant hirudin (CGP 39393) in plasma. Thromb Haemost 1990; 64: 464–468
   PubMedGoogle Scholar
• Kaiser B, Fareed J, Walenga J, Hoppensteadt D, Markwardt F. In vitro studies on thrombin generation in citrated, r-hirudinized and heparinized whole blood. Thromb Res 1991; 64: 589–596
   PubMed Web of Science ®Google Scholar
• Schneider D, Tracy P, Mann K, Sobel B. Differential effects of anticoagulants on the activation of platelets ex vivo. Circulation 1997; 96: 2877–2883
   PubMed Web of Science ®Google Scholar
• Harrison P. Assessment of platelet function in the laboratory. Hamostaseologie 2009; 29: 25–31
   PubMed Web of Science ®Google Scholar
• Scharbert G, Kalb M, Marschalek C, Kozek-Langenecker S. The effects of test temperature and storage temperature on platelet aggregation: A whole blood in vitro study. Anesth Analg 2006; 102: 1280–1284
   PubMed Web of Science ®Google Scholar
• Anderson ER, Foulks JG. Competitive inhibition by lithium and hydrogen ions of the effect of calcium on the aggregation of rabbit platelets. Thromb Haemost 1976; 36: 343–359
   PubMedGoogle Scholar
• de Meis L, Suzano VA. Uncoupling of muscle and blood platelets Ca2+ transport ATPases by heparin. Regulation by K+. J Biol Chem 1994; 269: 14525–14529
   PubMedGoogle Scholar
• Kuliczkowski W, Witkowski A, Polonski L, Watala C, Filipiak K, Budaj A, Golanski J, Sitkiewicz D, Pregowski J, Gorski J, et al. Interindividual variability in the response to oral antiplatelet drugs: A position paper of the Working Group on antiplatelet drugs resistance appointed by the Section of Cardiovascular Interventions of the Polish Cardiac Society, endorsed by the Working Group on Thrombosis of the European Society of Cardiology. Eur Heart J 2009; 30: 426–435
   PubMed Web of Science ®Google Scholar
• Ho C, Chan I. The influence of time of storage, temperature of storage, platelet number in platelet-rich plasma, packed cell, mean platelet volume, hemoglobin concentration, age, and sex on platelet aggregation test. Ann Hematol 1995; 71: 129–133
   PubMed Web of Science ®Google Scholar
• Bolliger D, Seeberger M, Tanaka K, Dell-Kuster S, Gregor M, Zenklusen U, Grapow M, Tsakiris D, Filipovic M. Pre-analytical effects of pneumatic tube transport on impedance platelet aggregometry. Platelets 2009; 20: 458–465
   PubMed Web of Science ®Google Scholar
• Savion N, Shenkman B, Tamarin I, Dardik R, Frojmovic M, Varon D. Transient adhesion refractoriness of circulating platelets under shear stress: The role of partial activation and microaggregate formation by suboptimal ADP concentration. Br J Haematol 2001; 112: 1055–1061
   PubMed Web of Science ®Google Scholar
• Scharbert G, Kalb ML, Essmeister R, Kozek-Langenecker SA. Mild and moderate hypothermia increases platelet aggregation induced by various agonists: A whole blood in vitro study. Platelets 2010; 21: 44–48
   PubMed Web of Science ®Google Scholar